Back to
Jacobs Levy Equity Management, Inc.
AXSM
Showing 1 of 7 quarters
Position history for
Jacobs Levy Equity Management, Inc.'s holdings in Axsome Therapeutics, Inc.
Yes. Jacobs Levy Equity Management holds 11,533 shares of AXSM (Axsome Therapeutics), worth $2.8M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$2.8M
Current Shares
11,533
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History